Novel evolved immunoglobulin (ig)-binding molecules enhance the detection of igm against hepatitis c virus

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Cao, Jie ^a   Chen, Qiuli ^a   Zhang, Huaqun ^a   Qi, Peipei ^a   Liu, Chao ^a   Yang, Xufang ^a   Wang, Niansong ^b,c   Qian, Baohua ^d   Wang, Jinhong ^a   Jiang, Shaohua ^a,e   Yang, Hua ^a,f   Sun, Shuhan ^a   Pan, Wei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e Department of Cardiothoracic Surgery   (China)

^f TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN BINDING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PEROXIDASE; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONJUGATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MASS SCREENING; VIRUS DETECTION; BLOOD; GENETIC PROCEDURES; IMMUNOLOGY; METABOLISM; PROTEIN BINDING;

ARMORACIA RUSTICANA; HEPATITIS C VIRUS;

BIOSENSING TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HUMANS; IMMUNOGLOBULIN M; PROTEIN BINDING;

EID: 79955040575     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018477     Document Type: Article

References (35)

1. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, et al. (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364.
2. Abdel-Hamid M, El-Daly M, El-Kafrawy S, Mikhail N, Strickland GT, et al. (2002) Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 40: 1656-9.
3. Alter HJ, (1992) New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology 15: 350-353.
4. Kleinman S, Alter H, Busch M, Holland P, Tegtmeier G, et al. (1992) Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 32: 805-813.
5. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, et al. (2005) Dynamics of viremia in early hepatitis C virus infection. Transfusion 45: 994-1002.
6. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, et al. (1991) Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325: 1325-1329.
7. Gretch DR, (1997) Diagnostic tests for hepatitis C. Hepatology26 (Suppl.1): 43S-47S.
8. Jiang SH, Wang JF, Xu R, Liu YJ, Wang XN, et al. (2008) Alternate Arrangement of PpL B3 Domain and SpA D Domain Creates Synergistic Double-Site Binding to VH3 and Vκ Regions of Fab. DNA and Cell Biology 27: 423-431.
9. Yang H, Cao J, Li LQ, Zhou X, Chen QL, et al. (2008) Evolutional selection of a combinatorial phage library displaying randomly-rearranged various single domains of immunoglobulin (Ig)-binding proteins (IBPs) with four kinds of Ig molecules. BMC Microbiology August 13, 2008, doi:10.1186/1471-2180-8-137.
10. León P, López JA, Elola C, Domingo CJ, Echevarria JM, (1996) Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV. Vox Sang 70: 213-216.
11. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, et al. (1990) Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 335: 1419-1422.
12. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, et al. (1990) Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med 60: 215-222.
13. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, et al. (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325: 98-104.
14. Puoti M, Zonaro A, Ravaggi A, Marin MG, Castelnuovo F, et al. (1992) Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. Hepatology 16: 877-881.
15. Hino K, Sainokami S, Shimoda K, Niwa H, Iino S, (1994) Clinical course of acute hepatitis C and changes in HCV markers. Dig Dis Sci 39: 19-27.
16. National Institutes of Health (1997) National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 26: 2S-10S.
17. Racine R, Winslow GM, (2009) IgM in microbial infections: taken for granted? Immunol Lett 125: 79-85.
18. Wang NS, Liao LT, (1998) Hemodialysis and hepatitis C virus. Guowai Yixue Liuxingbingxue Chuanranbingxue Fence (Chinese) 25: 115-118.
19. Boero R, Martina G, Bosio P, Devos S, Bertolo P, et al. (1995) HCV viremia in hemodialysis patients: detection by a DNA enzyme immunoassay for amplified HCV sequences. Renal Failure 17: 565-573.
20. Souqiyyeh MZ, Shaheen FAM, Huraib SO, Al-Khader AA, (1995) The annual incidence of seroconversion of antibodies to the hepatitis C virus in the hemodialysis population in Saudi Arabia. Saudi J Kidney Dis Transplant 6: 167-173.
21. Al-Faleh FZ, (1995) Hepatitis C virus infection: an update. Saudi J Kidney Dis Transplant 6: 118-121.
22. Wang NS, Liao LT, Zhu YJ, Pan W, Fang F, (2000) Follow-up study of hepatitis C virus infection in uremic patients on maintenance hemodialysis for 30 months. World J Gastroenterol 6: 888-892.
23. Huang CS, Ho MS, Yang CS, Lee CL, Tan CA, (1993) Hepatitis C markers in hemodialysis patients. J Clin Microbiol 31: 1764-1769.
24. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, et al. (1997) False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35: 174-178.
25. Verhofstede C, Van Renterghem L, Plum J, (1989) Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii. J Clin Pathol 42: 1285-1290.
26. Akbar SM, Onji M, Horiike N, Ohta Y, (1993) Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C. Gastroenterol Jpn 28 (Suppl 5): 71-75.
27. Yamaguchi N, Tokushige K, Yamauchi K, Hayashi N, (2000) Humoral immune response in Japanese acute hepatitis patients with hepatitis C virus infection. Can J Gastroenterol 14: 593-598.
28. Quinti I, Hassan NF, El Salman D, Shalaby H, El Zimatty D, et al. (1995) Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C. J Hepatol 23: 640-647.
29. Kikuchi T, Onji M, Michitaka K, Saito I, Miyamura T, et al. (1992) Anti-HCV immunoglobulin M antibody in patients with hepatitis C. J Gastroenterol Hepatol 7: 246-248.
30. Zaaijer HL, Mimms LT, Cuypers HT, Reesink HW, van der Poel CL, et al. (1993) Variability of IgM response in hepatitis C virus infection. J Med Virol 40: 184-187.
31. Quiroga JA, Campillo ML, Catillo I, Bartolomé J, Porres JC, et al. (1991) IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology 14: 38-43.
32. Rudich SM, Winchester R, Mongini PK, (1985) Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies. J Exp Med 162: 1236-1255.
33. Murphy RM, Slayter H, Schurtenberger P, Chamberlin RA, Colton CK, et al. (1988) Size and structure of antigen-antibody complexes. Electron microscopy and light scattering studies. Biophys J 54: 45-56.
34. Chevrier MC, Châteauneuf I, Guérin M, Lemieux R, (2004) Sensitive detection of human IgG in ELISA using a monoclonal anti-IgG-peroxidase conjugate. Hybrid Hybridomics 23: 362-367.
35. Welschof M, Terness P, Kipriyanov SM, Stanescu D, Breitling F, et al. (1997) The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody. Proc Natl Acad Sci USA 94: 1902-1907.